BlackRock Fund Advisors - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$144,604,000
+49.7%
4,042,599
+8.8%
0.04%
+33.3%
Q3 2014$96,572,000
-19.5%
3,714,312
+2.3%
0.03%
-20.6%
Q2 2014$120,007,000
+5.8%
3,631,075
-4.2%
0.03%0.0%
Q1 2014$113,417,000
+1.4%
3,789,420
+2.9%
0.03%0.0%
Q4 2013$111,810,000
-5.5%
3,682,792
-1.0%
0.03%
-15.0%
Q3 2013$118,347,000
+141.4%
3,720,449
+14.7%
0.04%
+122.2%
Q2 2013$49,031,0003,244,9290.02%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 549,425$16,680,0006.89%
Opaleye Management Inc. 205,000$5,945,000,0004.67%
Rhenman & Partners Asset Management AB 240,000$7,286,0002.85%
SECTORAL ASSET MANAGEMENT INC 1,774,919$53,887,0002.32%
Eventide Asset Management 242,700$7,368,0002.27%
OAK RIDGE INVESTMENTS LLC 2,713,717$82,389,0002.16%
First Light Asset Management, LLC 68,245$2,072,0001.76%
Broadfin Capital, LLC 400,000$12,144,0001.60%
Cupps Capital Management, LLC 748,175$22,714,0001.54%
FCG ADVISORS, LLC 70,651$2,145,0001.45%
View complete list of NPS PHARMACEUTICALS INC shareholders